Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medication, these kinds of devices which include a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with really very low permeability